
A Diabetes RELIEF Initiative: Realizing the Potential of GLP-1 Receptor Agonists in Type 2 Diabetes: Partnering with Patients to Improve Glycemic and Cardiovascular Outcomes
These online enduring podcasts focus on the role of GLP-1 receptor agonists in the care of patients with type 2 diabetes, including but not limited to, the glycemic and extra-glycemic effects and strategies to avoid adverse events of GLP-1 receptor agonists while enhancing the patient/provider partnership using a shared decision-making approach to the selection of GLP-1 receptor agonists.
RELEASED DATE: February 27, 2023
EXPIRATION DATE: March 23, 2024